Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

International Journal of Dental Hygiene, 2024
Activation of the Urokinase Plasminogen Activator/Urokinase Plasminogen Activator Receptor System in Periodontitis: A Case–Control Study

Khudhur A., Dowson C., Bissett S. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPatient StratificationSaliva

Cell Death Discovery, 2024
Cardiomyocyte and stromal cell cross-talk influences the pathogenesis of arrhythmogenic cardiomyopathy: a multi-level analysis uncovers DLK1-NOTCH pathway role in fibro-adipose remodelling

Maione A., Iengo L., Sala L. et al.

Olink Target 96CVDPathophysiologyCell Culture Supernatant

Autoimmunity, 2024
High throughput multiplex immunoassays stratify patients according to symptom burden across the anti-Ro positive systemic autoimmune rheumatic disease spectrum

Dyball S., Shukla R., Madenidou A. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Advanced Science, 2024
Chemogenomic Screening in a Patient‐Derived 3D Fatty Liver Disease Model Reveals the CHRM1‐TRPM8 Axis as a Novel Module for Targeted Intervention

Youhanna S., Kemas A., Wright S. et al.

Olink Target 96HepatologyPathophysiologyCell Culture Supernatant

Diabetes/Metabolism Research and Reviews, 2024
Prediction Model for Polyneuropathy in Recent‐Onset Diabetes Based on Serum Neurofilament Light Chain, Fibroblast Growth Factor‐19 and Standard Anthropometric and Clinical Variables

Maalmi H., Nguyen P., Strom A. et al.

Olink Target 96Metabolic DiseasesNeurologyPatient StratificationPlasma

Clinical Cardiology, 2024
Insulin‐Like Growth Factor Binding Protein 2 Predicts Right Ventricular Reverse Remodeling and Improvement of Concomitant Tricuspid Regurgitation After Transcatheter Edge‐to‐Edge Mitral Valve Repair

Gröger M., Felbel D., Paukovitsch M. et al.

Olink Target 96CVDPatient StratificationSerum

Diabetes, Obesity and Metabolism, 2024
Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease

Geng J., Ruan X., Wu X. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Gastroenterology, 2024
Preclinical Protein Signatures of Crohn’s Disease and Ulcerative Colitis: A Nested Case-Control Study Within Large Population-Based Cohorts

Grännö O., Bergemalm D., Salomon B. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Mucosal Immunology, 2024
Gut-homing and intestinal TIGITnegCD38+ memory T cells acquire an IL-12-induced, ex-Th17 pathogenic phenotype in a subgroup of Crohn’s disease patients with a severe disease course

Heredia M., Barendregt D., Tindemans I. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Cancer Letters, 2024
Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer

Steiner L., Eldh M., Offens A. et al.

Olink Target 96OncologyPatient StratificationEV Lysate

NeuroImage: Clinical, 2024
State-specific GluCEST alterations in insular subregions are associated with depression and plasma inflammatory biomarker levels in patients with inflammatory bowel disease

Xu L., Lu J., Zhou M. et al.

Olink Target 96Immunological & Inflammatory DiseasesNeurologyPathophysiologyPlasma

International Immunopharmacology, 2024
Causal effects of circulating inflammatory proteins on oral phenotypes: Deciphering immune-mediated profiles in the host-oral axis

Ye X., Chen T., Cheng J. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma

Cell, 2024
Atlas of the plasma proteome in health and disease in 53,026 adults

Deng Y., You J., He Y. et al.

Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma

CHEST, 2024
Plasma Protein Biomarkers of Spirometry Measures of Impaired Lung Function

Aggarwal M., Hwang S., Lee D. et al.

Olink Explore 3072/384Respiratory DiseasesPathophysiologyPlasma

Clinical Cancer Research, 2024
A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

Sweis R., Chatta G., Jain R. et al.

Olink Target 48OncologyImmunotherapyPatient StratificationSerum

Signal Transduction and Targeted Therapy, 2024
Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial

Liu J., Wang X., Li Z. et al.

Olink Target 96OncologyImmunotherapyPathophysiologySerum

BMC Infectious Diseases, 2024
Candidate serum protein biomarkers for active pulmonary tuberculosis diagnosis in tuberculosis endemic settings

Ayalew S., Wegayehu T., Wondale B. et al.

Olink Target 96Infectious DiseasesPatient StratificationSerum

Nature Genetics, 2024
Genome-wide association study reveals mechanisms underlying dilated cardiomyopathy and myocardial resilience

Jurgens S., Rämö J., Kramarenko D. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Metabolic Brain Disease, 2024
Accelerated cognitive aging in chronically infected HIV-1 positive individuals despite effective long-term antiretroviral therapy

Babu H., Rachel G., Neogi U. et al.

Olink Target 96NeurologyInfectious DiseasesAgingPathophysiologyPlasma

European Journal of Preventive Cardiology, 2024
Nonobese young females with polycystic ovary syndrome are at high risk for long-term cardiovascular disease

Zhao X., Wang J., Sun D. et al.

Olink Explore 3072/384CVDEndocrinologyPatient StratificationPlasma

2798 publications